TMP-269
CAS No. 1314890-29-3
TMP-269 ( TMP 269;TMP269 )
Catalog No. M11270 CAS No. 1314890-29-3
A potent and selective class IIa HDAC inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 59 | In Stock |
|
5MG | 87 | In Stock |
|
10MG | 148 | In Stock |
|
25MG | 247 | In Stock |
|
50MG | 445 | In Stock |
|
100MG | 537 | In Stock |
|
200MG | 773 | In Stock |
|
500MG | 1161 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTMP-269
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective class IIa HDAC inhibitor.
-
DescriptionA potent and selective class IIa HDAC inhibitor with IC50s of 126/80/36/19 nM for HDAC4/5/7/9; less potent or no inhibition for others HDAC isoforms (>2 uM); prevents cell cycle progression, DNA synthesis, and proliferation induced in response to G protein-coupled receptor/PKD1 activation in IEC-18 cells.
-
SynonymsTMP 269;TMP269
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC4;HDAC5;HDAC7;HDAC9
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1314890-29-3
-
Formula Weight514.52
-
Molecular FormulaC25H21F3N4O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 41 mg/mL
-
SMILESO=C(NCC1(C2=NC(C3=CC=CC=C3)=CS2)CCOCC1)C4=CC=CC(C5=NOC(C(F)(F)F)=N5)=C4
-
Chemical NameBenzamide, N-[[tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lobera M, et al. Nat Chem Biol. 2013 May;9(5):319-25.
2. Sinnett-Smith J, et al. Am J Physiol Cell Physiol. 2014 May 15;306(10):C961-71.
3. Kikuchi S, et al. Leukemia. 2015 Sep;29(9):1918-27.
2. Sinnett-Smith J, et al. Am J Physiol Cell Physiol. 2014 May 15;306(10):C961-71.
3. Kikuchi S, et al. Leukemia. 2015 Sep;29(9):1918-27.
molnova catalog
related products
-
SR-18292
SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
-
Remodelin hydrobromi...
A potent inhibitor of the acetyl-transferase protein NAT10 that acetylates both histones and microtubules.
-
Valproic acid
A HDAC inhibitor that selectively inhibits the catalytic activity of class I HDACs, and induces proteasomal degradation of HDAC2.